NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Terran Orbital Corporation ("Terran" or the "Company") (NYSE:LLAP) and certain officers. The class action, filed in the United States District Court for the Southern District Of Florida, and docketed under 24-cv-81191 is on […]

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Verve Therapeutics, Inc. ("Verve" or the "Company") (NASDAQ:VERV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Domino’s Pizza, Inc. ("Domino’s" or the "Company") (NYSE:DPZ) and certain officers. The class action, filed in the United States District Court for the Eastern District of Michigan, and docketed under 24-cv-12477, is on

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Agenus Inc. ("Agenus" or the "Company") (NASDAQ:AGEN) and certain officers. The class action, filed in the United States District Court for the District of Massachusetts, and docketed under 24-cv-12299, is on behalf of

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ:SAGE) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 24-cv-06511, is

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ:ARDX) and certain officers. The class action, filed in the United States District Court for the District of Massachusetts, and docketed under 24-cv-12119, is on behalf of

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE:ELAN) and certain officers. The class action, filed in the United States District Court for the District Of Maryland, and docketed under 24-cv-02912 is on

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against STMicroelectronics N.V. ("ST" or the "Company") (NYSE:STM) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 24-cv-06384, is on

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of ZoomInfo Technologies, Inc. (NASDAQ: ZI) between November 10, 2020 and August 5, 2024, both dates inclusive (the “Class Period”), of the important November 4, 2024 lead plaintiff deadline. SO

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022 and August 7, 2024, both dates inclusive (the “Class Period”) of the important October 28, 2024 lead plaintiff deadline. https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg So What: If you purchased Outset Medical securities during the Class Period